Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/06/2003 | WO2003018767A2 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
03/06/2003 | WO2003018752A2 An organotypic intestinal culture and methods of use thereof |
03/06/2003 | WO2003018743A2 Emu-based formulations for wound treatment |
03/06/2003 | WO2003018077A1 Method of bone regeneration |
03/06/2003 | WO2003018069A1 Preparation and diabetic use of gibberellins |
03/06/2003 | WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
03/06/2003 | WO2003018041A1 Method of treating spinal injury and remedy therefor |
03/06/2003 | WO2003018040A1 Composite graft for treatment of retinal diseases |
03/06/2003 | WO2003018039A1 Pharmaceutical ingredient for medical treatment and preventing of cancer |
03/06/2003 | WO2003017992A2 Means for treatment of atherosclerosis |
03/06/2003 | WO2003017920A2 Protective factors against inflammation, burns and noxious stimuli |
03/06/2003 | WO2003017913A1 Compositions, methods and apparatus for surgical procedures |
03/06/2003 | WO2003002131B1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
03/06/2003 | WO2002101021A3 Purification of human serum albumin |
03/06/2003 | WO2002095026A8 Method of proliferating terminal differentiated cells and recombinant vector therefor |
03/06/2003 | WO2002092122A3 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
03/06/2003 | WO2002088337B1 Olfactory ensheathing glia produced by introducing telomerase |
03/06/2003 | WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
03/06/2003 | WO2002066511A3 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
03/06/2003 | WO2002051994A8 Polypeptides |
03/06/2003 | WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
03/06/2003 | WO2002012325A3 Suppressor gene |
03/06/2003 | WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
03/06/2003 | WO2001074900A9 Nuclear factor kb inducing factor |
03/06/2003 | WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
03/06/2003 | US20030045943 Device for regeneration of articular cartilage and other tissue |
03/06/2003 | US20030045498 Contacting the ocular cell with an expression vector comprising the nucleic acid sequence encoding the inhibitor of angiogenesis and the nucleic acid sequence encoding the neurotrophic agent. |
03/06/2003 | US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present |
03/06/2003 | US20030044978 Expanded and genetically modified populations of human hematopoietic stem cells |
03/06/2003 | US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer |
03/06/2003 | US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide |
03/06/2003 | US20030044765 Use of cytokines and mitogens to inhibit pathological immune responses |
03/06/2003 | US20030044470 Mussel hydrolysate from Indian green mussel (Perna viridis) and at least one additive; method of extraction; inhibition of receptor activator of NF-KB ligand (RANKL) |
03/06/2003 | US20030044468 Shaping polymeric precursors by inducing thermal gelation of an aqueous solution thereof and then curing said precursors by crosslinking reactive groups; biomedical uses include drug delivery, microencapsulation, implantation |
03/06/2003 | US20030044397 In digestable carrier; therapy for liver disorders |
03/06/2003 | US20030044396 Tissue engineering; generating thymus tissue |
03/06/2003 | US20030044391 Preparation and xenotransplantation of porcine islets |
03/06/2003 | US20030044390 Applying stresses to blood sampling |
03/06/2003 | US20030044387 Liver cancer therapy |
03/06/2003 | US20030044386 Genetic engineering; nucleic acid coding cytokines |
03/06/2003 | US20030044385 Antitumor, anticancer agents |
03/06/2003 | US20030044384 Treatment of neoplasms with viruses |
03/06/2003 | US20030044383 Tissue specific adenoviral vectors |
03/06/2003 | US20030044381 Synthetic soil-extract materials and medicaments for influenza viruses based thereon |
03/06/2003 | US20030042435 Quartz schist comprising oxides of silicon, aluminum, and iron |
03/06/2003 | US20030042201 Supplying drinking water in situ |
03/06/2003 | US20030041386 Graft prosthesis, materials and methods |
03/06/2003 | CA2459974A1 Emu-based formulations for wound treatment related application information |
03/06/2003 | CA2458753A1 Compositions, methods and apparatus for surgical procedures |
03/06/2003 | CA2458362A1 Isolation of inner cell mass for the establishment of human embryonic stem cell (hesc) lines |
03/06/2003 | CA2458261A1 Differentiation of neural stem cells and therapeutic use thereof |
03/06/2003 | CA2458226A1 Improved nitroreductase enzymes |
03/05/2003 | EP1288299A2 TRNA synthetase |
03/05/2003 | EP1288291A1 Method of amplifying natural killer t cells |
03/05/2003 | EP1287362A2 Compositions and methods for modulating tumor specific expression |
03/05/2003 | EP1287120A2 Human circulating dendritic cell compositions and methods |
03/05/2003 | EP1287116A2 Neural progenitor cell populations |
03/05/2003 | EP1287115A2 Retinal pigment epithelial cell lines with extended life-span and their applications |
03/05/2003 | EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use |
03/05/2003 | EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer |
03/05/2003 | EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer |
03/05/2003 | EP1287025A1 Sheep lice, bovicola ovis, allergen treatment |
03/05/2003 | EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents |
03/05/2003 | EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
03/05/2003 | EP1286708A1 Method for producing a bio-artificial transplant |
03/05/2003 | EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
03/05/2003 | EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
03/05/2003 | EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
03/05/2003 | EP1286688A2 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs |
03/05/2003 | EP1286687A2 A method of treatment of huntington's chorea with a protein extractable from mammalian organs |
03/05/2003 | EP1286685A2 A method of treatment of parkinson's disease with a protein extractable from mammalian organs |
03/05/2003 | EP1286683A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
03/05/2003 | EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
03/05/2003 | EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues |
03/05/2003 | EP1286652A2 Skin protectant spray compositions |
03/05/2003 | EP1163004B1 Immunoadsorber for use in sepsis therapy |
03/05/2003 | EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
03/05/2003 | EP0845034B1 peptide having pronociceptive properties |
03/05/2003 | EP0822824A4 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel |
03/05/2003 | EP0804254B1 Heat treated blood plasma proteins |
03/05/2003 | EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor |
03/05/2003 | CN2538241Y Electric chafing dish with medical stone |
03/05/2003 | CN1400906A Treatment of congestive heart failure by pretreated autologous blood |
03/05/2003 | CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the |
03/05/2003 | CN1400008A Medicine for curing nasal sinusitis |
03/05/2003 | CN1400007A Oral Chinese medicine for curing osteoarthropathy |
03/05/2003 | CN1400005A Chinese medicine for boosting brain and supplementing kidney and its preparation method |
03/05/2003 | CN1400004A Chinese medicine preparation for curing chronic conjunctivitis |
03/05/2003 | CN1399999A Medicine for curing malignant turnor and its preparation method |
03/05/2003 | CN1399986A Medicine for curing sleepless |
03/05/2003 | CN1399979A Chinese medicine composition for curing cancers |
03/05/2003 | CN1399977A Medicine for curing prolapse of lumbar intervertebral disc and its preparation method |
03/05/2003 | CN1399976A Chinese medicine powder preparation for resisting thrombosis and its preparation method |
03/05/2003 | CN1399975A Medicine for curing peptic ulcer and its preparation method |
03/05/2003 | CN1399971A Biological preparation for curing burn and its preparation method |
03/05/2003 | CN1399970A Preparation method of silkworm dropping soluble preparation |
03/05/2003 | CN1399969A Production method of health-care food with auxiliary action for curing diabetos |
03/05/2003 | CN1399968A Health-care food and its production method |
03/05/2003 | CN1399967A Wound healing ointment |